1-((1,4-trans)-4-(4-Cyanophenoxy)cyclohexyl)-3-(4-cyanophenyl)urea

ID: ALA4059489

PubChem CID: 117954842

Max Phase: Preclinical

Molecular Formula: C21H20N4O2

Molecular Weight: 360.42

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  N#Cc1ccc(NC(=O)N[C@H]2CC[C@H](Oc3ccc(C#N)cc3)CC2)cc1

Standard InChI:  InChI=1S/C21H20N4O2/c22-13-15-1-5-17(6-2-15)24-21(26)25-18-7-11-20(12-8-18)27-19-9-3-16(14-23)4-10-19/h1-6,9-10,18,20H,7-8,11-12H2,(H2,24,25,26)/t18-,20-

Standard InChI Key:  IKFOHVKGCJSLEB-KESTWPANSA-N

Molfile:  

     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
   22.3929   -6.7604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3918   -7.5799    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0998   -7.9889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.8095   -7.5794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.8067   -6.7568    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0980   -6.3515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3147   -6.7810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3136   -7.6005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0216   -8.0095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7313   -7.6001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7285   -6.7774    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0198   -6.3721    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4346   -6.3661    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.1439   -6.7721    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8500   -6.3608    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.1469   -7.5893    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.5593   -6.7667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5600   -7.5825    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2652   -7.9883    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9738   -7.5805    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9727   -6.7624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2630   -6.3520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6815   -7.9891    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.5106   -6.3443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2168   -5.9331    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.6098   -8.0084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9017   -8.4164    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
 17 15  1  6
 17 18  1  0
 17 22  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 20 23  1  1
 23  2  1  0
 24 25  3  0
  5 24  1  0
 26 27  3  0
  8 26  1  0
M  END

Alternative Forms

Associated Targets(non-human)

Eif2ak1 Eukaryotic translation initiation factor 2-alpha kinase 1 (86 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 360.42Molecular Weight (Monoisotopic): 360.1586AlogP: 3.94#Rotatable Bonds: 4
Polar Surface Area: 97.94Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.26CX Basic pKa: CX LogP: 3.56CX LogD: 3.56
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.86Np Likeness Score: -1.16

References

1. Yefidoff-Freedman R, Fan J, Yan L, Zhang Q, Dos Santos GRR, Rana S, Contreras JI, Sahoo R, Wan D, Young J, Dias Teixeira KL, Morisseau C, Halperin J, Hammock B, Natarajan A, Wang P, Chorev M, Aktas BH..  (2017)  Development of 1-((1,4-trans)-4-Aryloxycyclohexyl)-3-arylurea Activators of Heme-Regulated Inhibitor as Selective Activators of the Eukaryotic Initiation Factor 2 Alpha (eIF2α) Phosphorylation Arm of the Integrated Endoplasmic Reticulum Stress Response.,  60  (13): [PMID:28590739] [10.1021/acs.jmedchem.7b00059]

Source